Cargando…

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases

Detalles Bibliográficos
Autor principal:	Nandakumar, Kutty Selva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963674/ https://www.ncbi.nlm.nih.gov/pubmed/36851080 http://dx.doi.org/10.3390/vaccines11020202

Ejemplares similares

THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”
por: Retnakumar, Sruthi Vijaya, et al.
Publicado: (2023)

Polymer Chemistry Defines Adjuvant Properties and Determines the Immune Response against the Antigen or Vaccine
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action
por: Wilson, Heather L., et al.
Publicado: (2021)

A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines
por: Zhang, Naru, et al.
Publicado: (2022)

Advances in Infectious Disease Vaccine Adjuvants
por: Fan, Jingyi, et al.
Publicado: (2022)

Recent Advances of Vaccine Adjuvants for Infectious Diseases
por: Lee, Sujin, et al.
Publicado: (2015)

Next Generation Vaccines for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2019)

Vaccines against Infectious Diseases and Cancer
por: Sousa, Ângela, et al.
Publicado: (2022)

Vaccines, adjuvants and autoimmunity
por: Guimarães, Luísa Eça, et al.
Publicado: (2015)

Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
por: Nandakumar, Kutty Selva
Publicado: (2018)

A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Arenaviral vaccine vectors to combat infectious diseases
por: Dhanwani, Rekha, et al.
Publicado: (2016)

COVID-19 Vaccination and the Development of Autoimmune Diseases
por: Yoshimi, Ryusuke, et al.
Publicado: (2023)

Biomarkers and Pathogenesis of Infectious and Autoimmune Diseases
por: Rizvanov, Albert A.
Publicado: (2022)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease
por: Lim, Yong Taik
Publicado: (2015)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine
por: Renu, Sankar, et al.
Publicado: (2021)

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2006)

Novel Vaccine Adjuvants
por: Agrawal, Anshu, et al.
Publicado: (2013)

Editorial: Systemic lupus erythematosus - predisposition factors, pathogenesis, diagnosis, treatment and disease models
por: Nandakumar, Kutty Selva, et al.
Publicado: (2022)

Molecular therapies and vaccines face the challenges of emerging infectious diseases
por: Patel, Ami, et al.
Publicado: (2022)

Vaccination of patients with autoimmune inflammatory rheumatic disease: physicians’ perspectives
por: Moon, Ki Won
Publicado: (2023)

Dendritic Cells: Immune Response in Infectious Diseases and Autoimmunity
por: Sesti-Costa, Renata, et al.
Publicado: (2020)

Current Progress in the Development of Zika Virus Vaccines
por: Zhou, Kehui, et al.
Publicado: (2021)

In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases
por: McGarvey, Peter B, et al.
Publicado: (2014)

Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
por: Grunwald, Thomas, et al.
Publicado: (2015)

The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine
por: Yao, Yiyang, et al.
Publicado: (2023)

Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines
por: Rapaka, Rekha R., et al.
Publicado: (2021)

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2021)

Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Tocotrienols are good adjuvants for developing cancer vaccines
por: Abdul Hafid, Sitti Rahma, et al.
Publicado: (2010)

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Suresh, Lakshmanan
Publicado: (2021)

BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers
por: Mustafa, Abu Salim
Publicado: (2020)

Vaccinations and Autoimmune Diseases
por: Olivieri, Bianca, et al.
Publicado: (2021)

A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2010)

Vaccine Development against Infectious Diseases: State of the Art, New Insights, and Future Directions
por: Conceição Silva, Fatima, et al.
Publicado: (2023)

Polymorphic estrogen receptor binding site causes Cd2-dependent sex bias in the susceptibility to autoimmune diseases
por: Fernandez Lahore, Gonzalo, et al.
Publicado: (2021)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
por: Yang, Jing-Xing, et al.
Publicado: (2022)

Infectious Diseases and Vaccination for Rabies
por: Pasteur, M.
Publicado: (1884)

Cannot write session to /tmp/vufind_sessions/sess_8i9i4f13jn25ai6qnfq17pmdr7